DE WAAL, LUC,MEYERSON, MATTHEW,GREULICH, HEIDI,SCHENONE, MONICA,BURGIN, ALEX,WU, XIAOYUN,SACK, ULRIKE
申请号：
CA2995375
公开号：
CA2995375A1
申请日:
2016.08.12
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention features improved methods of identifying patients having cancer (e.g., melanoma, adenocarcinoma, lung, cervical, liver or breast cancer) using biomarkers (e.g., PDE3A, SLFN12) that correlate with drug sensitivity and consequently treating a stratified patient population with an agent of the invention (e.g., DNMDP, zardaverine, and anagrelide).
